KLRK1 and non-small cell lung carcinoma: Konrad Kokowski et al. have shown that the combination of NK cell transfer and radiochemotherapy with second-line PD-1 inhibition improved the overall survival of a patient with NSCLC stage IIIb and induced a massive NKG2D + immune cell infiltration (Kokowski, Stangl et al., 2019).